US Bancorp
NUVB icon

US Bancorp’s Nuvation Bio NUVB Stock Holding History

US Bancorp’s Portfolio NUVB Stock Details NUVB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$9.5K Buy
1,704
+116
+7% +$728 ﹤0.01% 3509
2026
Q2 		$9.02K Buy
1,588
+7
+0.4% +$34 ﹤0.01% 3486
2026
Q1 		$6.78K Buy
1,581
+106
+7% +$591 ﹤0.01% 3482
2025
Q4 		$13.2K Hold
1,475
– – ﹤0.01% 3234
2025
Q3 		$5.46K Hold
1,475
– – ﹤0.01% 3513
2025
Q2 		$2.88K Hold
1,475
– – ﹤0.01% 3789
2025
Q1 		$2.6K Sell
1,475
-1,396
-49% -$3.18K ﹤0.01% 3823
2024
Q4 		$7.64K Buy
2,871
+630
+28% +$1.62K ﹤0.01% 3515
2024
Q3 		$5.13K Hold
2,241
– – ﹤0.01% 3562
2024
Q2 		$6.54K Hold
2,241
– – ﹤0.01% 3437
2024
Q1 		$8.16K Buy
+2,241
New +$4.3K ﹤0.01% 3402
2023
Q1 		– Sell
-261
Closed -$501 – 4174
2022
Q4 		$501 Buy
+261
New +$528 ﹤0.01% 4001

Other funds holding NUVB

Laurion Capital Management
Laurion Capital Management New York $6.21B AUM 32.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Essex Investment Management
Essex Investment Management Boston, Massachusetts $675M AUM 61.81% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
ACPLP
ACT Capital Partners, L.P. Wayne, Pennsylvania $154M AUM
ALPS Advisors
ALPS Advisors Denver, Colorado $21.8B AUM 17.58% 1-Year Est. Return
Hennion & Walsh Asset Management
Hennion & Walsh Asset Management Parsippany, New Jersey $3.42B AUM 25.82% 1-Year Est. Return
Tema ETFs
Tema ETFs New York $2.69B AUM 42.96% 1-Year Est. Return

US Bancorp's NUVB Position: Q3 2026 in Review

US Bancorp increased its Nuvation Bio (NUVB) stake by 7.3% in Q3 2026, buying an estimated $728 and bringing the position to 1,704 shares worth $9.5K. The position accounts for ﹤0.01% of the portfolio, ranked #3509.

US Bancorp first reported a position in NUVB in Q4 2022 and has held it in 12 quarters since. The position peaked at $13.2K in Q4 2025. 87 funds tracked by Wall St. Rank hold NUVB as of Q3 2026.

  • US Bancorp held 1,704 shares of Nuvation Bio worth $9.5K as of Q3 2026.
  • US Bancorp bought 116 Nuvation Bio shares in Q3 2026, an estimated $728.
  • Nuvation Bio made up ﹤0.01% of US Bancorp's portfolio in Q3 2026, its #3509 holding.
  • US Bancorp first reported a position in Nuvation Bio in Q4 2022 and has held it in 12 quarters since.
  • US Bancorp's Nuvation Bio position peaked at $13.2K in Q4 2025.
  • 87 funds tracked by Wall St. Rank held Nuvation Bio as of Q3 2026.

Based on US Bancorp's 13F filing for Q3 2026, filed 5 Nov 2026.